MEDICINOVA, INC. Increase (Decrease) in Accounts Receivable
MEDICINOVA, INC. (MNOV) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- MEDICINOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$245.10K, a 282.10% decline year-over-year.
- MEDICINOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $245.10K.
- MEDICINOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $134.60K.
- MEDICINOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|---|---|
| 2026-06-30 | -$245.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $245.10K 10-Q · filed 2026-05-14 | ||
| 2025-06-30 | $134.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $134.60K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-13 | ||
| 2021-03-31 | $4.00M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |